Introduction {#S1}
============

The increasing bloodstream infections mainly in developing countries is the one of most important health care systems concerne. Although the bloodstream infections mortality rate has reduced in latest two decades. Many studies worldwide have determined rising antibiotics resistance among causative bacteria for septicemia \[[@R01]-[@R03]\]. It can can lead to make a major challenge for the physicians for treatment of tham, because of they face to increase of antibiotics resistance in causative bacteria for septicemia \[[@R03]-[@R05]\].

Both Gram-negative and Gram-positive bacteria can cause bloodstream infections and that can be differs from different locality and/or different time \[[@R01], [@R02], [@R08]\]. Rapid and accurate diagnosis and select the appropriate antimicrobial treatment for patients with septicemia can help to decrease mortality and morbidity \[[@R07], [@R09]\]. Actually, for selection of empirical antibiotic therapy for bloodstream infections consider local antibiotic resistance paterns in frequent pathogens associated with septicemia is necessary and can be one of important point.

So, this study was performed to find the frequency of Gram-negative bacteria that causing septicemia in Children\'s Medical Center hospital admitted patients and determined antimicrobial resistance profile till clinicians can select the best choice antibiotic therapy.

Methods {#S2}
=======

This study was performed at a Children\'s Medical Center, Tehran, Iran, over a period of twelve months from July 2010 to 2011 July. During the current study, 803 blood samples from patients of clinically suggestive bloodstream infection were surveyed, out of 4162 patients admitted. An informed consent was achieved from the patients. Blood samples from neonates and pediatrics were collected by pediatricians. Blood samples were gathered after careful cleaning of the venous with 70% alcohol and consequently followed by povidone iodine. Under the aseptic conditions 5 ml of blood was drawn by venipuncture and transmitted into two culture bottles each containing 50 ml of 0.5% bile-broth and 50 ml of 0.5% glucose-broth. Both the bottles were incubated at 37°C for 10 days aerobically. Routine subculturing was performed on MacConkey agar and 5% sheep blood agar after 24 hours, 48 hours, 5th day and 10th day. In between these time points, subculturing was performed until there was observable turbidity. Microorganisms that isolated from blood culture were recognized by cultural characters, morphology and variety of standard biochemical tests such as oxidase,TSI, SIM, citrate, OF, Lysine decarboxilase, gelatinase, MR/VP, etc. \[[@R10]-[@R15]\]

Antimicrobial resistant patterns of the bacterial isolates to several antimicrobials was detected by using the Kirby Bauer disc diffusion method by Clinical and Laboratory Standards Institute (CLSI) guidelines \[[@R11]\]. The antibiotic concentration for each disc was as follows: gentamicin (10μg), amikacin (30μg), ampicillin (10μg), amoxicillin (30μg), amoxiclav (20:10μg), cefoxitin (30μg), cefotaxime (30μg), cefuroxime (30μg), ceftazidime (30μg), cefoperazone (75μg), ciprofloxacin (5μg), tetracycline (30μg) and chloramphenicol (30μg) for all organisms. All the antibiotic discs were purchased from MAST company (UK).

Results {#S3}
=======

Demographics {#S3a}
------------

Over a period of twelve months from July 2010 to 2011 July. 11446 blood samples from patients of clinically suggestive septicemia were evaluated. The causative organism could be identified in 910 (7.95%) bacterial strains. Gram-negative bacteria identified were *Pseudomonas* species 187 (20.5%), *Acinetobacter baumannii* 74 (8.13%), *Klebsiella* spp 47 (5.16%), *Escherichia coli* 37 (4.06%), *Salmonella* spp 10 (1.09%), *Pseudomonas aeruginosa* 17 (1.86%) ([Tab. I](#T1){ref-type="table"}).

###### 

Number and percentage of isolated Species of Bacterial.

  Species of isolated Bacterial   Number of isolated bacteria   Percentage of isolated bacteria
  ------------------------------- ----------------------------- ---------------------------------
  Pseudomonas species             187                           20.5%
  Acinetobacter baumannii         74                            8.13
  Klebsiella spp                  47                            5.16%
  Escherichia coli                37                            4.06%
  Pseudomonas aeruginosa          17                            1.86%
  Salmonella spp                  10                            1.09%

The rates of resistance in *Pseudomonas* spp to various antimicrobials are given below: gentamicin (30.1%), amikacin (10.8%), ampicillin (87.8%), amoxicillin (96%), amoxiclav (80.02%), cefuroxime (69%), cefotaxime (49.4%), cefazidime (35.2%), cefoperazone (39.1%), ciprofloxacin (22%), chloramphenicol (59%) and tetracycline (32.1 %) ([Tab. II](#T2){ref-type="table"}).

###### 

Frequency of antibiotics resistance.

                             gentamicin   amikacin   ampicillin   amoxicillin   amoxiclav   cefuroxime   cefotaxime   cefazidime   cefoperazone   ciprofloxacin   chloramphenicol   tetracycline
  -------------------------- ------------ ---------- ------------ ------------- ----------- ------------ ------------ ------------ -------------- --------------- ----------------- --------------
  *Pseudomonas* spp.         30.1%        10.8%      87.8%        96%           80.02%      69%          49.4%        35.2%        39.1%          22%             59%               32.1%
  *Acinetobacter* species    11.5%        3.7%       84.2 %       83.2%         80.1%       75.4%        44.8%        45.2%        33.3%          19%             34.1%             32%
  *Salmonella* spp.          21%          39%        46.4%        27.3%         15.4%       \-           \-           \-           32.5%          6.3%            9.1%              50%
  *Escherichia coli*         25%          18%        92%          90.9%         73.9%       54.5%        52.9%        \-           36.8%          31.6%           39%               39%
  *Pseudomonas aeruginosa*   42.2%        30.8%      96.1%        92.9%         95.8%       81%          48.4%        34.2%        47.3%          22.4%           32%               42.6%
  *Klebsiella* spp.          54%          0%         98.7%        52%           52%         77.4%        52%          \-           32%            0%              49%               62%

The rates of resistance in *Acinetobacter* species to various antimicrobials are given below: gentamicin (11.5%), amikacin (3.7%), ampicillin (84.2 %), amoxicillin (83.2%), amoxiclav (80.1%), cefuroxime (75.4%), cefotaxime (44.8%), ceftazidime (45.2%), cefoperazone (33.3%), ciprofloxacin (19%),, chloramphenicol (34.1%) and tetracycline (32%) ([table. 2](#T2){ref-type="table"}).

The rates of resistance in *Salmonella* spp to various antimicrobials are given below: cefuroxime (21%), cefotaxime (39%), ampicillin (46.4%), amoxicillin (27.3%), amoxiclav (15.4%), cefoperazone (32.5%),, ciprofloxacin (6.3%), chloramphenicol (9.1%) and tetracycline (50%) ([Tab. II](#T2){ref-type="table"}).

The rates of resistance in *Escherichia coli* to various antimicrobials are given below: gentamicin (25%), amikacin (18%), ampicillin (92%), amoxicillin (90.9%), amoxiclav (73.9%), cefuroxime (54.5%), cefotaxime (52.9%), cefoperazone (36.8%), ciprofloxacin (31.6%), chloramphenicol (39%) and tetracycline (33.7%) ([Tab. II](#T2){ref-type="table"}).

The rates of resistance in *Pseudomonas aeruginosa* to various antimicrobials are given below: gentamicin (42.2%), amikacin (30.8%), ampicillin (96.1%), amoxicillin (92.9%), amoxiclav (95.8%), cefuroxime (81%), cefotaxime (48.4%), cefazidime (34.2%), cefoperazone (47.3%), ciprofloxacin (22.4%), chloramphenicol (32%) and tetracycline (42.6 %) ([table. 2](#T2){ref-type="table"}).

The rates of resistance in *Klebsiella* spp to various antimicrobials are given below: gentamicin (54%), chloramphenicol (49%) cefuroxime (77.4%), cefotaxime (52%), ampicillin (98.7%), amoxicillin (71.4%), amoxiclav (52%), cefoperazone (32%) and tetracycline (62%). Klebsiella pneumoniae did not show resistance to amikacin and ciprofloxacin ([Tab. II](#T2){ref-type="table"}).

Discussion {#S4}
==========

Bacterial antibiotics resistant is remaining as an allarming problem in the therapy of bloodstream infections \[[@R16], [@R17]\]. Bacterial bloodstream infection mostly caused by strains that are resistant to a wide range of antimicrobial agents \[[@R18]\]. The current study investigated the antimicrobial resistance profile of 372 Gram-negative bacteria isolated from bloodstream infections. The data demonestrated the frequency of antimicrobial resistance among bacterial pathogens isolated from bloodstream infections.

Gram-negative bacteria is the most cause of bloodstream infections in many conties \[[@R01], [@R02], [@R07], [@R18]\]. Also, this type of bacteria have been the most common contributing pathogens of bloodstream infections in the present study. This is considerable that, different etiological agents of bloodstream infections can be related to the varying demography of bloodstream infections in developing countries because of different geographical area.

In some studies demonstrated that *Acinetobacter* species, Salmonella typhi and Escherichia coli were the most common Gram-nagative bacteria that involve in that bloodstream infections \[[@R19]-[@R21]\]. These results are approximately similar to our results in current study.

Gram-negative bacteria is more resistance to antibiotics than Gram-positive. *Acinetobacter* species demonstrated very high levels of resistance to beta-lactam antibiotics in some reports \[[@R22], [@R23]\], that it is similar to the results of current study. *Acinetobacter* species showed the lower levels of resistance to aminoglycoside and low level resistance rates to quinolones. Similarly, *Escherichia coli* demonstrated distinctly higher levels of resistance to beta-lactam antibiotics than other classes of antimicrobials. The organism demonstrated maximum resistance to ampicillin and minimum to amikacin \[[@R22], [@R23]\]. These results can support the finding of this study, because of our results of antibiotic susceptibility testing are similar to them.

Conclusions {#S5}
===========

Extensive frequency of antimicrobial resistance levels were distinguished in our study, is similar to another studies \[[@R17], [@R18]\]. The high frequency of antibiotic resistance rates in Children\'s Medical Center might be because of indifferentiate and excess of use of treatment in our country because of their easy availability \[[@R19]\]. The other cause might be frequency of ESBL production among Gram-negative isolates from neonatal bloodstream infection \[[@R20]\]. Also, other cause could be the altering patterns of antibiotic utilize and varies in lifestyle. In the light of over findings there continues an increasing requirement for new agents, though a recent study reported polymyxin are being restored to as potential choices for the therapy \[[@R21]\]. Proper antimicrobial treatment for bloodstream infections is important in declining morbidity and mortality among patients with bloodstream infections caused by bacteria. Therefore, accurate microbiological diagnosis and their antimicrobial resistance profile can be very important for the rapid initiation of sufficient treatment for bloodstream infections \[[@R23]\].
